World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
29600
World Ranking
15476
National Ranking
7806

Nicholas Mitsiades publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nicholas Mitsiades sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 225 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nicholas Mitsiades D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nicholas Mitsiades sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nicholas Mitsiades is affiliated with Baylor College of Medicine in the United States. Their research primarily focuses on medical and molecular biology fields with significant contributions to oncology and pulmonary medicine. Mitsiades's work intersects areas such as prostate cancer treatment and research, cancer genomics and diagnostics, and the study of epigenetics and DNA methylation.

Their recent publications reflect a strong emphasis on cancer biology and therapeutics. Notable papers include:

  • Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment, 2021, Nature Communications
  • Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics, 2022, Cancer Letters
  • The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response, 2022, Cancer Research
  • Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer, 2021, Endocrine Related Cancer
  • Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP, 2020, Journal of Medicinal Chemistry

Frequent co-authors collaborating with Mitsiades include Salma Kaochar, Mamta Parikh, Heidi Dowst, Michael E. Scheurer, and Martha P. Mims.

The scientist has published extensively in several venues, particularly in:

  • Cancer Research
  • Journal of Clinical Oncology
  • The Journal of Urology
  • Proceedings of the National Academy of Sciences
  • Endocrine Related Cancer

Nicholas Mitsiades's main fields of study are Medicine and Biochemistry, Genetics, and Molecular Biology. They have contributed notably in subfields such as Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Oncology, and Radiology, Nuclear Medicine and Imaging.

Their work covers a variety of specialized topics, including:

  • Prostate Cancer Treatment and Research
  • Cancer Genomics and Diagnostics
  • Prostate Cancer Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Epigenetics and DNA Methylation
  • Cancer Immunotherapy and Biomarkers
  • Protein Degradation and Inhibitors

Best Publications

  • Integrative genomic profiling of human prostate cancer

    Barry S. Taylor;Nikolaus Schultz;Haley Hieronymus;Anuradha Gopalan

  • NF-κB as a Therapeutic Target in Multiple Myeloma *

    Teru Hideshima;Dharminder Chauhan;Paul Richardson;Constantine Mitsiades

  • Molecular sequelae of proteasome inhibition in human multiple myeloma cells

    Nicholas Mitsiades;Constantine S. Mitsiades;Vassiliki Poulaki;Dharminder Chauhan

  • The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.

    Nicholas Mitsiades;Constantine S. Mitsiades;Paul G. Richardson;Vassiliki Poulaki

  • Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

    Nicholas Mitsiades;Constantine S. Mitsiades;Vassiliki Poulaki;Dharminder Chauhan

  • Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

    Constantine S Mitsiades;Nicholas S Mitsiades;Nicholas S Mitsiades;Ciaran J McMullan;Vassiliki Poulaki;Vassiliki Poulaki

  • Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

    Teru Hideshima;Constantine Mitsiades;Masaharu Akiyama;Toshiaki Hayashi

  • Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.

    Antonia M. Joussen;Vassiliki Poulaki;Nicholas Mitsiades;Bernd Kirchhof

  • Transcriptional signature of histone deacetylase inhibition in multiple myeloma: Biological and clinical implications

    Constantine S. Mitsiades;Nicholas S. Mitsiades;Ciaran J. McMullan;Vassiliki Poulaki

  • Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

    Richard LeBlanc;Laurence P Catley;Teru Hideshima;Suzanne Lentzsch

  • Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.

    Constantine S Mitsiades;Nicholas Mitsiades;Vassiliki Poulaki;Robert Schlossman

  • Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

    Nicholas Mitsiades;Wei-hsuan Yu;Vassiliki Poulaki;Maria Tsokos

  • TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

    Constantine S. Mitsiades;Steven P. Treon;Nicholas Mitsiades;Yoshihito Shima

  • Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications

    Nicholas Mitsiades;Constantine S. Mitsiades;Vassiliki Poulaki;Dharminder Chauhan

  • Antimyeloma activity of heat shock protein-90 inhibition.

    Constantine S. Mitsiades;Nicholas S. Mitsiades;Ciaran J. McMullan;Vassiliki Poulaki

  • Retinal Vascular Endothelial Growth Factor Induces Intercellular Adhesion Molecule-1 and Endothelial Nitric Oxide Synthase Expression and Initiates Early Diabetic Retinal Leukocyte Adhesion in Vivo

    Antonia M. Joussen;Antonia M. Joussen;Antonia M. Joussen;Vassiliki Poulaki;Vassiliki Poulaki;Wenying Qin;Wenying Qin;Bernd Kirchhof

  • Molecular sequelae of histone deacetylase inhibition in human malignant B cells

    Nicholas Mitsiades;Constantine S. Mitsiades;Paul G. Richardson;Ciaran McMullan

  • Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

    Douglas W McMillin;Jake Delmore;Jake Delmore;Ellen Weisberg;Ellen Weisberg;Joseph M Negri;Joseph M Negri

  • Immunomodulatory drug costimulates T cells via the B7-CD28 pathway.

    Richard LeBlanc;Teru Hideshima;Laurence P. Catley;Reshma Shringarpure

  • The Akt pathway: molecular targets for anti-cancer drug development.

    Constantine S. Mitsiades;Nicholas Mitsiades;Michael Koutsilieris

Frequent Co-Authors

Constantine S. Mitsiades
Constantine S. Mitsiades Harvard University
Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Paul G. Richardson
Paul G. Richardson Harvard University
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Dharminder Chauhan
Dharminder Chauhan Harvard University
Robert L. Schlossman
Robert L. Schlossman Harvard University
Cristian Coarfa
Cristian Coarfa Baylor College of Medicine
Klaus Podar
Klaus Podar Karl Landsteiner University of Health Sciences
Steven P. Treon
Steven P. Treon Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine doesn’t always mean attending medical school. There are several valuable online degrees and career pathways in healthcare that offer flexibility, affordability, and fast-tracked options for advancement.

For those interested in patient care, affordable online nursing programs allow students to earn nursing credentials without the high costs and relocation burdens of traditional colleges. Furthering your education can be cost-effective, too—consider the cheapest online dnp programs to earn a Doctor of Nursing Practice and expand your career opportunities in leadership, research, and advanced practice.

If you’re an RN looking to boost your qualifications, the cheapest rn to bsn program options can help you quickly transition into higher-level nursing roles. Alternatively, professionals from other backgrounds can explore direct entry online msn programs for non-nurses, providing a fast track into the nursing profession.

These online pathways not only make healthcare education more accessible but also support faster entry and advancement in this high-demand field.

Best Scientists Citing Nicholas Mitsiades

Trending Scientists

Recently Published Articles